{
  "Question": "Co-Diagnostics., Inc. (Co-Dx) CES 2024 product highlight and specification",
  "Summary": "Co-Diagnostics, Inc. (Co-Dx)\n\nCES 2024\n\n- Co-Diagnostics, Inc. (Co-Dx) is showcasing its innovative molecular diagnostics platform at CES 2024.\n- The platform offers high accuracy and rapid results for infectious disease testing.\n- It utilizes Co-Dx's proprietary CoPrimer technology, enabling multiplex testing for multiple pathogens in a single reaction.\n- The platform is designed for easy integration into existing laboratory workflows, making it suitable for a wide range of testing environments.\n- Co-Dx's technology has the potential to significantly improve the efficiency and accuracy of infectious disease testing, with applications in healthcare, veterinary medicine, and agriculture."
}